Evidence map›Paper›PMID 30240201›Full record

ArticleJournal of agricultural and food chemistry2018

Oral Administration of Salecan-Based Hydrogels for Controlled Insulin Delivery.

Xiaoliang Qi, Yue Yuan, Jianfa Zhang, Jeff W M Bulte, Wei Dong

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Journal of agricultural and food chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 133 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Xiaoliang QiCenter for Molecular Metabolism , Nanjing University of Science & Technology , Nanjing 210094 , China.
Yue Yuan
Jianfa ZhangCenter for Molecular Metabolism , Nanjing University of Science & Technology , Nanjing 210094 , China.
Jeff W M BulteDepartment of Oncology , The Johns Hopkins University School of Medicine , Baltimore , Maryland 21287 , United States.
Wei DongCenter for Molecular Metabolism , Nanjing University of Science & Technology , Nanjing 210094 , China.ORCID http://orcid.org/0000-0002-6712-8960
Nanjing University of Science and Technology · CNJohns Hopkins University · USKennedy Krieger Institute · US

Funding

Dual-mode MRI for in vivo sensing of microcapsule stability and biocompatibilityR01DK106972 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI BULTE, JEFF W. · 2015 to 2018
$1.7M
NIDDK NIH HHS R01 DK106972
6 · The paper itself

Abstract

We present an improved type of food gum (salecan) based hydrogels for oral delivery of insulin. Structural hydrogel formation was assessed with Fourier transform infrared spectroscopy, thermogravimetric analysis, and X-ray diffraction. We found that the hydrogel modulus, morphology, and swelling properties can be controlled by varying the salecan dose during hydrogel formation. Insulin was introduced into the hydrogel using a swelling-diffusion approach and then further used a drug prototype. In vitro insulin release profiles demonstrated that the release of entrapped insulin was suppressed in acidic conditions but markedly increased at neutral pH. Cell viability and toxicity tests revealed that the salecan hydrogel constructs were biocompatible. Oral administration of insulin-loaded salecan hydrogels in diabetic rats resulted in a sustained decrease of fasting plasma glucose levels over 6 h postadministration. For nondiabetic animals, the relative pharmacological bioavailability of insulin was significantly larger (6.24%, p < 0.05) for insulin-loaded hydrogels compared to free insulin. These results encourage further development of salecan-based hydrogels as vehicles for controlled insulin delivery following oral administration.

Indexed as

Administration, OralAnimalsbeta-GlucansCell SurvivalDelayed-Action PreparationsDiabetes Mellitus, ExperimentalDrug Delivery SystemsExcipientsHumansHydrogelsHydrogen-Ion ConcentrationInsulinRatsRats, WistarSpectroscopy, Fourier Transform InfraredThermogravimetrybeta-GlucansDelayed-Action PreparationsExcipientsHydrogelsInsulinsalecandrug deliveryhydrogelsinsulinoralsalecan polysaccharides

Identifiers

PMID30240201
PMCPMC7764162
OpenAlexW2891457650

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.